NYSEAMERICAN:XXII22nd Century Group Stock Price, Forecast & News Adding Choose a watchlist: Adding You have already added five stocks to your watchlist. Upgrade to MarketBeat Daily Premium to add more stocks to your watchlist. Adding 22nd Century Group Inc Please log in to your account or sign up in order to add this asset to your watchlist. Log In and Add $0.73 -0.01 (-1.55 %) (As of 08/7/2020 04:00 PM ET) Add Compare Share Today's Range$0.72Now: $0.73▼$0.7550-Day Range N/A52-Week Range$0.60Now: $0.73▼$2.46Volume695,437 shsAverage Volume1.48 million shsMarket Capitalization$101.29 millionP/E RatioN/ADividend YieldN/ABetaN/A ProfileAnalyst RatingsAdvanced ChartCompetitorsEarningsInsider TradesInstitutional OwnershipHeadlinesOptions ChainSocial Media 22nd Century Group, Inc., a plant biotechnology company, provides technology that allows increasing or decreasing the level of nicotine and other nicotinic alkaloids in tobacco plants, and cannabinoids in hemp/cannabis plants through genetic engineering and plant breeding. It offers premium cigarettes under the RED SUN and MAGIC brands; and SPECTRUM research cigarettes for use in independent clinical studies. The company's products under development include BRAND A, a very low nicotine content cigarette; X-22, a tobacco-based botanical medical product for use as an aid to smoking cessation; and BRAND B, a low-tar-to-nicotine ratio cigarette. It is also involved in contract manufacturing business for third-party branded tobacco products. The company has a strategic research and development agreement with Keygene N.V. to develop hemp/cannabis plants for medical and therapeutic use, and other applications. 22nd Century Group, Inc. was founded in 1998 and is headquartered in Williamsville, New York.Read More Beat the Market (BTM) Rank™ 0.0 Analyst's Opinion Consensus RatingThere is not enough analysis data for 22nd Century Group. Previous Next 2.7 Community Rank Outperform Votes22nd Century Group has received 333 “outperform” votes. (Add your “outperform” vote.)Underperform Votes22nd Century Group has received 275 “underperform” votes. (Add your “underperform” vote.)Community Sentiment22nd Century Group has received 54.77% “outperform” votes from our community.MarketBeat's community ratings are surveys of what our community members think about 22nd Century Group and other stocks. Vote “Outperform” if you believe XXII will outperform the S&P 500 over the long term. Vote “Underperform” if you believe XXII will underperform the S&P 500 over the long term. You may vote once every thirty days. Previous Next 0.0 Dividend Strength Dividend Yield22nd Century Group does not currently pay a dividend.Dividend Growth22nd Century Group does not have a long track record of dividend growth. Previous Next 3.0 Company Ownership Insider Buying vs. Insider SellingIn the past three months, 22nd Century Group insiders have bought more of their company's stock than they have sold. Specifically, they have bought $97,207.00 in company stock and sold $0.00 in company stock. Previous Next 0.0 Earnings and Valuation Previous Next Analyst Opinion: 0.0Community Rank: 2.7Dividend Strength: 0.0Insider Behavior: 3.0Valuation: 0.0 5 -4 -3 -2 -1 -Overall Beat the Market Rank™1.14 out of 5 stars Industry, Sector and Symbol Stock Exchange NYSEAMERICAN Industry Biotechnology Sub-IndustryCannabis SectorMedical Current SymbolNYSEAMERICAN:XXII Previous SymbolAMEX:XXII CUSIPN/A CIKN/A Webwww.xxiicentury.com Phone+1-716-2701523Debt Debt-to-Equity RatioN/A Current RatioN/A Quick RatioN/APrice-To-Earnings Trailing P/E RatioN/A Forward P/E RatioN/A P/E GrowthN/A Sales & Book Value Annual SalesN/A Price / SalesN/A Cash FlowN/A Price / Cash FlowN/A Book ValueN/A Price / BookN/AProfitability EPS (Most Recent Fiscal Year)N/A Net IncomeN/A Net MarginsN/A Return on EquityN/A Return on AssetsN/AMiscellaneous Employees82 Outstanding Shares138,854,000Market Cap$101.29 million Next Earnings Date11/5/2020 (Estimated) OptionableOptionable $0.73 -0.01 (-1.55 %) (As of 08/7/2020 04:00 PM ET) 30 days | 90 days | 365 days | Advanced Chart Receive XXII News and Ratings via Email Sign-up to receive the latest news and ratings for XXII and its competitors with MarketBeat's FREE daily newsletter. 22nd Century Group (NYSEAMERICAN:XXII) Frequently Asked Questions When is 22nd Century Group's next earnings date? 22nd Century Group is scheduled to release its next quarterly earnings announcement on Thursday, November 5th 2020. View our earnings forecast for 22nd Century Group. How were 22nd Century Group's earnings last quarter? 22nd Century Group Inc (NYSEAMERICAN:XXII) released its quarterly earnings results on Thursday, August, 6th. The biotechnology company reported ($0.04) earnings per share for the quarter, missing the consensus estimate of ($0.04) by $0.00. View 22nd Century Group's earnings history. Has 22nd Century Group been receiving favorable news coverage? Media headlines about XXII stock have been trending very positive recently, InfoTrie Sentiment reports. The research firm identifies negative and positive media coverage by monitoring more than six thousand news and blog sources. The firm ranks coverage of companies on a scale of negative five to five, with scores closest to five being the most favorable. 22nd Century Group earned a media sentiment score of 4.0 on InfoTrie's scale. They also gave news stories about the biotechnology company a news buzz of 0.0 out of 10, indicating that recent media coverage is extremely unlikely to have an effect on the stock's share price in the next few days. View the latest news about 22nd Century Group. Who are some of 22nd Century Group's key competitors? Some companies that are related to 22nd Century Group include Canopy Growth (WEED), Canopy Growth (CGC), Innovative Industrial Properties (IIPR), GrowGeneration (GRWG), OrganiGram (OGI), Emblem (EMC), ICC Labs (ICC), Bioventix (BVXP), KushCo (KSHB), General Cannabis (CANN), Grow Capital (GRWC), Terra Tech (TRTC), mCig (MCIG), Leafbuyer Technologies (LBUY) and Nemus Bioscience (NMUS). View all competitors. What other stocks do shareholders of 22nd Century Group own? Based on aggregate information from My MarketBeat watchlists, some companies that other 22nd Century Group investors own include Cara Therapeutics (CARA), Canopy Growth (CGC), Novavax (NVAX), Cronos Group (CRON), Aurora Cannabis (ACB), KushCo (KSHB), Terra Tech (TRTC), Micron Technology (MU), Zynerba Pharmaceuticals (ZYNE) and Aurora Cannabis (ACBFF). Who are 22nd Century Group's key executives? 22nd Century Group's management team includes the following people: Mr. Henry Sicignano III, MBA, Pres, CEO & Director (Age 51)Mr. John T. Brodfuehrer, CFO & Treasurer (Age 61)Mr. Thomas L. James J.D., Esq., VP, Gen. Counsel & Sec. (Age 60)James Vail, Director of CommunicationsMr. James C. Morrison, Technical Advisor & Regulatory Affairs Consultant What is 22nd Century Group's stock symbol? 22nd Century Group trades on the New York Stock Exchange (NYSE)AMERICAN under the ticker symbol "XXII." Who are 22nd Century Group's major shareholders? 22nd Century Group's stock is owned by many different institutional and retail investors. Top institutional shareholders include Raymond James Financial Services Advisors Inc. (0.08%), Heritage Wealth Advisors (0.04%), UBS Group AG (0.04%) and Wealthcare Advisory Partners LLC (0.03%). Company insiders that own 22nd Century Group stock include Clifford B Fleet, Nora B Sullivan and Thomas L James. View institutional ownership trends for 22nd Century Group. Which institutional investors are selling 22nd Century Group stock? XXII stock was sold by a variety of institutional investors in the last quarter, including UBS Group AG, and Heritage Wealth Advisors. View insider buying and selling activity for 22nd Century Group. Which institutional investors are buying 22nd Century Group stock? XXII stock was purchased by a variety of institutional investors in the last quarter, including Wealthcare Advisory Partners LLC, and Raymond James Financial Services Advisors Inc.. Company insiders that have bought 22nd Century Group stock in the last two years include Clifford B Fleet, and Nora B Sullivan. View insider buying and selling activity for 22nd Century Group. How do I buy shares of 22nd Century Group? Shares of XXII can be purchased through any online brokerage account. Popular online brokerages with access to the U.S. stock market include Vanguard Brokerage Services, TD Ameritrade, E*TRADE, Robinhood, Fidelity, and Charles Schwab. What is 22nd Century Group's stock price today? One share of XXII stock can currently be purchased for approximately $0.73. How big of a company is 22nd Century Group? 22nd Century Group has a market capitalization of $101.29 million. 22nd Century Group employs 82 workers across the globe. What is 22nd Century Group's official website? The official website for 22nd Century Group is www.xxiicentury.com. How can I contact 22nd Century Group? 22nd Century Group's mailing address is 9530 Main St, CLARENCE, NY 14031-1915, United States. The biotechnology company can be reached via phone at +1-716-2701523. This page was last updated on 8/8/2020 by MarketBeat.com Staff 30 Days of MarketBeat All Access for $1.00 Sign up for MarketBeat All Access to gain access to MarketBeat's full suite of research tools: Best-in-Class Portfolio Monitoring View the latest news, buy/sell ratings, SEC filings and insider transactions for your stocks. Compare your portfolio performance to leading indices and get personalized stock ideas based on your portfolio. Stock Ideas and Recommendations Get daily stock ideas top-performing Wall Street analysts. Get short term trading ideas from the MarketBeat Idea Engine. View which stocks are hot on social media with MarketBeat's trending stocks report. Advanced Stock Screeners and Research Tools Identify stocks that meet your criteria using seven unique stock screeners. See what's happening in the market right now with MarketBeat's real-time news feed. Export data to Excel for your own analysis. Start Your Risk-Free Trial Subscription Here Questions? Get Started with MarketBeat — Read Your Daily NewsletterCheck Out My MarketBeatWatch Our Tutorial VideosAdd a Stock to Your WatchlistSet Up an Instant AlertView a Company's Profile PageView Our Financial CalendarsView Today's Analyst Ratings
